Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

NCT02176850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19870

Last updated 2014-07-08

No results posted yet for this study

Summary

This post-marketing surveillance study was designed to supplement under conditions of normal clinical practice the data on the safety, tolerability and efficacy of Micardis® collected during the clinical studies.

Conditions

Interventions

DRUG

Micardis®

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-31
Primary Completion
2000-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02176850 on ClinicalTrials.gov